1. Home
  2. BGSF vs TIL Comparison

BGSF vs TIL Comparison

Compare BGSF & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BGSF Inc.

BGSF

BGSF Inc.

N/A

Current Price

$6.09

Market Cap

65.8M

ML Signal

N/A

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

N/A

Current Price

$8.42

Market Cap

74.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BGSF
TIL
Founded
2007
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.8M
74.7M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
BGSF
TIL
Price
$6.09
$8.42
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
$9.00
$125.00
AVG Volume (30 Days)
23.2K
21.1K
Earning Date
03-11-2026
05-12-2026
Dividend Yield
33.06%
N/A
EPS Growth
67.37
52.54
EPS
N/A
N/A
Revenue
$272,499,000.00
N/A
Revenue This Year
$4.67
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.91
$5.67
52 Week High
$8.20
$42.75

Technical Indicators

Market Signals
Indicator
BGSF
TIL
Relative Strength Index (RSI) 52.98 48.96
Support Level $5.93 $8.14
Resistance Level $6.38 $9.27
Average True Range (ATR) 0.26 0.45
MACD -0.05 -0.04
Stochastic Oscillator 33.72 36.18

Price Performance

Historical Comparison
BGSF
TIL

About BGSF BGSF Inc.

BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: